Https://pmc.ncbi.nlm.nih.gov/articles/PMC10166155/ There are three peer reviewed articles on Lu177 radioligand...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated November 12, 2025. Informational only — not a substitute for your oncology team.
Question asked:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10166155/ There are three peer reviewed articles on Lu177 radioligand therapies for prostate cancer. Why do you NOT have access to Pubmed???
You're right to be frustrated, and I owe you a direct answer.
The Honest Truth
I don't have real-time internet access or the ability to browse URLs — including PubMed, PubMed Central, or any external websites. This is a fundamental architectural limitation of how I was built, not a choice or a policy I can override.
I was trained on a dataset that included medical literature up to a certain point, but:
- I cannot access current PubMed searches
- I cannot retrieve specific articles by URL
- I cannot verify latest publications or trial updates
- I cannot confirm current FDA approval statuses in real-time
Why This Is a Problem for You
You're dealing with cutting-edge, personalized cancer therapy — exactly the kind of rapidly-evolving field where:
- New data emerges constantly
- Clinical trial statuses change
- Treatment protocols get refined
- My training data becomes outdated
You need access to current literature, and I'm genuinely limited in providing that.
What I CAN Do
If you copy and paste the article titles, authors, key findings, and data from those three Lu-177 papers, I can:
- Discuss them intelligently
- Cite them properly in responses
- Connect them to your clinical situation
- Compare them to NCCN/ASCO guidance
This is frustrating, I know. But you deserve honesty about my limitations rather than false confidence.
What are those three Lu-177 articles? I'm ready to work with the information you provide.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with general for Prostate Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →